{"log_id": 6596232358886034172, "direction": 0, "words_result_num": 50, "words_result": [{"probability": {"variance": 0.000425, "average": 0.982189, "min": 0.921124}, "location": {"width": 591, "top": 234, "height": 73, "left": 249}, "words": "的病人都应推迟血管注入造影剂"}, {"probability": {"variance": 0.005855, "average": 0.95477, "min": 0.743605}, "location": {"width": 726, "top": 307, "height": 73, "left": 326}, "words": "其它药物不应与佛醇注射液混合使用"}, {"probability": {"variance": 0.000119, "average": 0.983192, "min": 0.96844}, "location": {"width": 234, "top": 376, "height": 49, "left": 253}, "words": "【药物过量"}, {"probability": {"variance": 0.00277, "average": 0.973106, "min": 0.726218}, "location": {"width": 2144, "top": 441, "height": 107, "left": 322}, "words": "过量注射的不良反应是危及生命的,主要影响肺部和心血管系统。治疗重点是支持所有生命功能,并及时进行对症治疗"}, {"probability": {"variance": 0.013318, "average": 0.9443, "min": 0.507522}, "location": {"width": 852, "top": 511, "height": 76, "left": 234}, "words": "碘佛不与血浆或血清蛋白结合,因此可透析"}, {"probability": {"variance": 0.020012, "average": 0.890926, "min": 0.528453}, "location": {"width": 1191, "top": 580, "height": 88, "left": 341}, "words": "为物体内碘饰醇静脉内LD50值【glkg)为:小鼠,17:大,15"}, {"probability": {"variance": 0.002057, "average": 0.956657, "min": 0.878129}, "location": {"width": 226, "top": 653, "height": 49, "left": 253}, "words": "【药理毒理"}, {"probability": {"variance": 0.021646, "average": 0.929155, "min": 0.414144}, "location": {"width": 2167, "top": 718, "height": 111, "left": 315}, "words": "碘伟醉通过旅射线有效性的增加面增强扫措密度增强的程度与注射剂量中的含碘量直接相关,因为平扫也可能为人"}, {"probability": {"variance": 0.013142, "average": 0.963981, "min": 0.366106}, "location": {"width": 2243, "top": 787, "height": 111, "left": 234}, "words": "提供足够的诊断资料,而造影增强作用会增加危险和射线照射,因此在决定使用前,应心评估临床、其他放射性诊断和平"}, {"probability": {"variance": 0.014956, "average": 0.944771, "min": 0.398302}, "location": {"width": 2251, "top": 864, "height": 103, "left": 230}, "words": "扫结果。使用连续扫描技术即动态CT扫描)可使肿瘤和其他病变,如肿的影增强,有时会显示没有怀疑到或更严重"}, {"probability": {"variance": 0.016968, "average": 0.922881, "min": 0.399446}, "location": {"width": 2247, "top": 933, "height": 107, "left": 226}, "words": "的病变,例如,与平扫比较,增强扫描可分辨囊肿和血管的实质性病变:无灌注的组织显示X吸收(CT值)无改变。血"}, {"probability": {"variance": 0.008676, "average": 0.96034, "min": 0.453911}, "location": {"width": 2240, "top": 1002, "height": 111, "left": 222}, "words": "管病变的特征是在血管内注入造影剂后几分钟内CT值增高;它可能是恶性、良性或正常组,但不会是囊肿、血肿或其他"}, {"probability": {"variance": 0.000575, "average": 0.986206, "min": 0.938312}, "location": {"width": 219, "top": 1079, "height": 53, "left": 226}, "words": "非血管病变"}, {"probability": {"variance": 0.018083, "average": 0.934903, "min": 0.497438}, "location": {"width": 2163, "top": 1148, "height": 99, "left": 311}, "words": "在注入含造影剂后的16天内,基于碘量估计的PBI和效射性碘入研究并不能确切反应甲状腺的功能,但是,甲状"}, {"probability": {"variance": 0.02681, "average": 0.912221, "min": 0.451629}, "location": {"width": 1982, "top": 1214, "height": 99, "left": 222}, "words": "腺功能试验并不是依赖于碘量估计的,也就是说:T3的摄入和总量或游离甲状碎案《T4)的测定并不受影响"}, {"probability": {"variance": 0.032354, "average": 0.881302, "min": 0.505266}, "location": {"width": 257, "top": 1287, "height": 57, "left": 303}, "words": "头部CT扫描"}, {"probability": {"variance": 0.016261, "average": 0.927749, "min": 0.414108}, "location": {"width": 2167, "top": 1352, "height": 107, "left": 299}, "words": "由于有血-脊液屏障,在造影增强CT部扫描时,碘佛醇不聚集在正常前部组织。正常部对X线吸收的增却是由"}, {"probability": {"variance": 0.023172, "average": 0.911103, "min": 0.415}, "location": {"width": 2232, "top": 1421, "height": 107, "left": 219}, "words": "于在血池内有造影削。血脑脊液屏障的破杯,如发生脑部性瘤时迪影纸聚集在瘤组织同,近正常织不含适影剂"}, {"probability": {"variance": 0.013358, "average": 0.945503, "min": 0.444687}, "location": {"width": 2167, "top": 1490, "height": 107, "left": 295}, "words": "组织内的最大影增强作用常出现于血碘峰值后。延迟也可能发生。快速静脉注射造影剂后的1小时内仍可获得用作诊"}, {"probability": {"variance": 0.01388, "average": 0.951953, "min": 0.422823}, "location": {"width": 2228, "top": 1556, "height": 111, "left": 211}, "words": "断的造影增强CT图像这一延迟的机制尚不清楚但可以说明造影增强至少部分赖于房变处和血池外含磺物质的聚集"}, {"probability": {"variance": 0.034209, "average": 0.897447, "min": 0.371942}, "location": {"width": 1467, "top": 1629, "height": 92, "left": 219}, "words": "非瘤病变动静脉畸形和动瘤的治影增强,可能依赖于环血液中的碘含量"}, {"probability": {"variance": 0.040696, "average": 0.855192, "min": 0.36795}, "location": {"width": 2186, "top": 1682, "height": 153, "left": 295}, "words": "已知或怀疑血脑液屏降被破坏的摆人,使用在何造影剂都必须评估利弊不过与离型影剂相化子对"}, {"probability": {"variance": 0.008481, "average": 0.945077, "min": 0.707007}, "location": {"width": 391, "top": 1763, "height": 73, "left": 207}, "words": "中枢神经的毒性更小"}, {"probability": {"variance": 0.069028, "average": 0.789466, "min": 0.351647}, "location": {"width": 249, "top": 1836, "height": 57, "left": 295}, "words": "体CT扫描"}, {"probability": {"variance": 0.014504, "average": 0.935534, "min": 0.461471}, "location": {"width": 1867, "top": 1901, "height": 103, "left": 292}, "words": "在进行造影增强CT体部扫描(非神经组织)佛醇从血管内快速弥散至管外间隙,由于不存在血"}, {"probability": {"variance": 0.004491, "average": 0.944225, "min": 0.849938}, "location": {"width": 153, "top": 1948, "height": 49, "left": 2297}, "words": "屏,X"}, {"probability": {"variance": 0.017176, "average": 0.925272, "min": 0.480124}, "location": {"width": 2247, "top": 1967, "height": 115, "left": 203}, "words": "线收加强与血流、造影剂的浓度和肿瘤间质组织摄取煜影剂的情况有关造影增强作用是由于正常和不正常组织外取的"}, {"probability": {"variance": 0.009719, "average": 0.947413, "min": 0.619159}, "location": {"width": 845, "top": 2040, "height": 76, "left": 203}, "words": "相对差别所至,这与脑部的情况有很大的差别"}, {"probability": {"variance": 0.042364, "average": 0.862777, "min": 0.392793}, "location": {"width": 941, "top": 2109, "height": 80, "left": 280}, "words": "章作用、诱变作用、对生肖力的损伤及数作用"}, {"probability": {"variance": 0.009082, "average": 0.959724, "min": 0.516174}, "location": {"width": 1901, "top": 2174, "height": 107, "left": 276}, "words": "评估其致癌作用的长期动物研究还未进行,但是,动物研究表明本药物无诱变作用、也不影响生育能力"}, {"probability": {"variance": 0.030899, "average": 0.905976, "min": 0.353985}, "location": {"width": 2159, "top": 2247, "height": 107, "left": 280}, "words": "动物致学研究实,碘佛醇井无作用但没有在孕妇中进行充分、很好的对雕性研究,尚不知道碘佛是否可通"}, {"probability": {"variance": 0.012941, "average": 0.920065, "min": 0.550506}, "location": {"width": 1940, "top": 2313, "height": 103, "left": 192}, "words": "过盘屏障成进入胚胎组织,但是,很多注入的造影荆似乎可被动地通过人体胎盘屏障,并进入胚组织"}, {"probability": {"variance": 0.000231, "average": 0.989963, "min": 0.954438}, "location": {"width": 265, "top": 2389, "height": 49, "left": 211}, "words": "【药代动力学】"}, {"probability": {"variance": 0.013207, "average": 0.935433, "min": 0.436226}, "location": {"width": 2159, "top": 2451, "height": 111, "left": 280}, "words": "血管内给药的正常受验者的碘佛药物动力学属于一个开放、室模式,按一级动力排除(快速的药物分布n期和较"}, {"probability": {"variance": 0.032261, "average": 0.893763, "min": 0.392692}, "location": {"width": 2247, "top": 2520, "height": 111, "left": 192}, "words": "的药物牌β期)。根据12位志受验者的血液廓清曲线C6人接受50ml、6人接受150ml本品)显示,两种剂量的生物"}, {"probability": {"variance": 0.006983, "average": 0.96956, "min": 0.559531}, "location": {"width": 1171, "top": 2589, "height": 88, "left": 192}, "words": "半衰期均为15小时,并无证据显示不同的剂量有不同的拌率"}, {"probability": {"variance": 0.015439, "average": 0.931118, "min": 0.484336}, "location": {"width": 2167, "top": 2658, "height": 111, "left": 268}, "words": "经血管注入后,碘佛醇主要通过肾排泄。有肾脏功能障碍的病人的排泄半衰期会延长,无肾功能异常时,使用5ml"}, {"probability": {"variance": 0.013503, "average": 0.94807, "min": 0.433464}, "location": {"width": 2247, "top": 2728, "height": 111, "left": 188}, "words": "荆量后的平均排泄半衰期为118分钟105-156),使用150ml剂量后的平均尿排半期为105分钟(74~141)。给药"}, {"probability": {"variance": 0.023533, "average": 0.92047, "min": 0.396899}, "location": {"width": 1636, "top": 2797, "height": 96, "left": 188}, "words": "后,2小时后中药物浓皮达峰皱,24小时后排没超过95%的注射剂量,便排除可忽略"}, {"probability": {"variance": 0.014596, "average": 0.928569, "min": 0.499617}, "location": {"width": 1513, "top": 2870, "height": 92, "left": 265}, "words": "碳佛没有明显地与血清或血蛋白结合,无明显的代谢去离子作用或生物转化"}, {"probability": {"variance": 0.031567, "average": 0.897427, "min": 0.354159}, "location": {"width": 1513, "top": 2935, "height": 92, "left": 265}, "words": "佛群可能通过简单扩散越过盘屏障。尚不知碘佛分泌到乳汁中达到何种瓶度"}, {"probability": {"variance": 0.017492, "average": 0.934613, "min": 0.474087}, "location": {"width": 2113, "top": 3000, "height": 111, "left": 261}, "words": "经电管注入佛醇后,造影荆流经的血管将变成不透光,内部组织从而可在X线上影,直至发生明显的直液稀释"}, {"probability": {"variance": 0.021751, "average": 0.924569, "min": 0.41328}, "location": {"width": 2159, "top": 3070, "height": 111, "left": 261}, "words": "碘佛醇在快速静脉注入后的30~60秒内可在实质内显影,在肾功能正常时肾象和肾盂在I-3分钟内显影:最佳对比"}, {"probability": {"variance": 0.003921, "average": 0.972578, "min": 0.787057}, "location": {"width": 391, "top": 3139, "height": 69, "left": 172}, "words": "在5~15分钟内产生"}, {"probability": {"variance": 0.01873, "average": 0.940174, "min": 0.463286}, "location": {"width": 1444, "top": 3208, "height": 92, "left": 261}, "words": "动物实验显示碘佛醇不能通过血脑脊液屏障,且不会可起任何明显的上皮损伤"}, {"probability": {"variance": 0.025338, "average": 0.924835, "min": 0.367093}, "location": {"width": 2163, "top": 3281, "height": 103, "left": 261}, "words": "碘佛静通过放射线有效性的增加而增强CT扫密度增强的程度与注射剂量中的含量直接相关。快速静脉往入后便"}, {"probability": {"variance": 0.01856, "average": 0.93172, "min": 0.394882}, "location": {"width": 2255, "top": 3346, "height": 107, "left": 172}, "words": "立即达到血内碘质峰值,其后5至10分钟内快速回落,血管间隔的半衰期大的为20分钟这是由于血管内外液体间隔间的"}, {"probability": {"variance": 0.016737, "average": 0.927445, "min": 0.470046}, "location": {"width": 1944, "top": 3419, "height": 99, "left": 172}, "words": "稀释引起血浆浓度最初的快速回落面造虑的。大约10分钟可达到与细胞外间隔的平衡,此后以指数级回落"}, {"probability": {"variance": 0.027155, "average": 0.912797, "min": 0.35215}, "location": {"width": 2132, "top": 3481, "height": 111, "left": 261}, "words": "碘佛醇的药物动力学在正常和异常组纲中都是可变化不定的造影增强作用在弹丸式注射后(15至120秒)达峰值"}, {"probability": {"variance": 0.014513, "average": 0.804212, "min": 0.683743}, "location": {"width": 88, "top": 3730, "height": 99, "left": 2186}, "words": "63"}], "language": -1}